![Michelle Griffin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Michelle R.
Griffin is an Independent Director at Adaptive Biotechnologies Corp.
since 2019.
Former roles include Independent Director at Acer Therapeutics, Inc. (2017–2023) and Chinook Therapeutics, Inc. (2020–2023); Chairman at Universal Cells, Inc. (2017–2018); Director at Sonus Pharmaceuticals, Inc. (2004–2008), Virginia Mason Medical Center (2014–2018), Virginia Mason Health System (2014–2018), PhaseRx, Inc. (2016–2018), Polynoma LLC (2012–2014), and Opexa Therapeutics, Inc.; Independent Director at HTG Molecular Diagnostics, Inc.; Director at Corixa Corp.
(2014–2017); Controller at Corixa Corp.
(2014–2017); Chief Financial Officer & Senior Vice President at Dendreon Corp.
(2005–2006); Chief Executive & Operating Officer, Senior VP at Emergent Product Development Seattle (2009–2010); Chief Operating Officer & Senior Vice President at Emergent Product Development Seattle (2011–2013); Chief Financial Officer & Executive VP-Operations at OncoGenex Pharmaceuticals, Inc. (2011–2013); Chief Financial Officer at Corixa Corp.
(1997–2005); Principal at Pacific Biotechnology Consulting Group (2013–2020).
Education includes undergraduate studies at George Mason University and an MBA from Seattle University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Director/Miembro de la Junta | 01/03/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| ACER THERAPEUTICS INC. | Director/Miembro de la Junta | 17/11/2023 |
| CHINOOK THERAPEUTICS, INC. | Director/Miembro de la Junta | 11/08/2023 |
Pacific Biotechnology Consulting Group
 Pacific Biotechnology Consulting Group Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biotechnology companies | Corporate Officer/Principal | 01/01/2020 |
| PHASERX, INC. | Director/Miembro de la Junta | 01/01/2018 |
Universal Cells, Inc.
 Universal Cells, Inc. BiotechnologyHealth Technology Developing, licenses and commercializes stem cell therapies | Presidente | 01/01/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 18 |
|---|---|
Sonus Pharmaceuticals, Inc.
 Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and related therapies | Health Technology |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Health Technology |
HTG Molecular Diagnostics, Inc.
 HTG Molecular Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides molecular technology solutions | Commercial Services |
Universal Cells, Inc.
Universal Cells, Inc. BiotechnologyHealth Technology Developing, licenses and commercializes stem cell therapies | Health Technology |
Virginia Mason Medical Center
 Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Provides integrated health services | Health Services |
George Mason University
 George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seattle University
 Seattle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
PhaseRx, Inc.
 PhaseRx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures enzyme replacement therapies | Health Technology |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Polynoma LLC
 Polynoma LLC Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company that develops a novel vaccine for the adjuvant treatment of stage IIB and IIC melanoma | Health Technology |
Virginia Mason Health System
 Virginia Mason Health System Hospital/Nursing ManagementHealth Services Provides medical services | Health Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
Pacific Biotechnology Consulting Group
Pacific Biotechnology Consulting Group Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biotechnology companies | Commercial Services |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
